| 【Company Research】Jiumaojiu (9922 HK) – Profit inline despite drags from mini outbreak |
| 【Fixed Income Research】ZHLGHD - Prepared for the upcoming maturities |
| 【Fixed Income Research】SUNSHI - Relative slower sales is mitigated by vigilant land investment |
| 【Company Research】Venus Medtech (Hangzhou) Inc. (2500 HK) – Strong growth momentum in 1H21 |
| 【Fixed Income Research】EVERRE/TIANHL - Cancellation of special dividend proposal is credit negative |
| 【Sector Research】China Insurance – Transfer of Coverage; 1H21 preview: Worst case already priced in |
| 【Company Research】AK Medical (1789 HK) – Channel destocking may continue |
| 【Fixed Income Research】EDU – We suggest Buy on EDU, as we see support from its 101 repurchase term on Triggering Event |
| 【Company Research】Haidilao (6862 HK) – Profit missed but all eyes on future reforms |
| 【Sector Research】China Property Service Sector – Long-term thesis stays unchanged; Pair trade opportunities amid macro and parentco risks |
公司地址：香港中环花园道三号冠君大厦45-46楼
电话：（852）3900-0888 传真：（852）3761-8788
招银国际版权所有 Copyright © 2019-2025 CMB International Capital Corporation Limited. All rights reserved.
